Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Bruss

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Health Management Technology|February 8, 2005
Mastering the supply chain. Challenged with saving dollars 30 million in 18 months, Illinois' largest IDN combines integrated business applications with organizationwide best practicesJon Bruss
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|April 14, 2006
Controlling implant costsKaren Barrow, Jon Bruss, John Gaida, et al.
Pharmacotherapy|July 14, 2018
Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN TrialsBoris Nogid, Melinda K Lacy, Micah Jacobs, et al.
The Pediatric Infectious Disease Journal|April 12, 2003
Linezolid versus cefadroxil in the treatment of skin and skin structure infections in childrenKenneth Wible, Miguel Tregnaghi, Jon Bruss, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2017
Evaluation of the bactericidal activity of Telavancin against Staphylococcus aureus using revised testing guidelinesDebora Sweeney, Dean L Shinabarger, Jennifer I Smart, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206Jon Bruss, Troy Lister, Vipul K Gupta, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2022
Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Vipul Gupta, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2022
Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal ImpairmentGina Patel, Keith A Rodvold, Vipul K Gupta, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Health Management Technology|February 8, 2005
Mastering the supply chain. Challenged with saving dollars 30 million in 18 months, Illinois' largest IDN combines integrated business applications with organizationwide best practicesJon Bruss
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|April 14, 2006
Controlling implant costsKaren Barrow, Jon Bruss, John Gaida, et al.
Pharmacotherapy|July 14, 2018
Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN TrialsBoris Nogid, Melinda K Lacy, Micah Jacobs, et al.
The Pediatric Infectious Disease Journal|April 12, 2003
Linezolid versus cefadroxil in the treatment of skin and skin structure infections in childrenKenneth Wible, Miguel Tregnaghi, Jon Bruss, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2017
Evaluation of the bactericidal activity of Telavancin against Staphylococcus aureus using revised testing guidelinesDebora Sweeney, Dean L Shinabarger, Jennifer I Smart, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206Jon Bruss, Troy Lister, Vipul K Gupta, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2022
Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Vipul Gupta, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2022
Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal ImpairmentGina Patel, Keith A Rodvold, Vipul K Gupta, et al.
Pageof 1